An observational study in Allergy;Food and Allergy, Nut, sponsored by Central Hospital, Nancy, France. Status unknown. Open to participants aged 0 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-24.
Sponsored by Central Hospital, Nancy, France · Observational
The objectives of the CAJESITO study are (i) to assess the tolerance of oral cashew nut immunotherapy, by describing the frequency and severity of allergic reactions during oral cashew nut immunotherapy and (ii )to assess the risk factors for severe allergic reactions during oral cashew nut immunotherapy (predictive factors, associated factors.
33 studies on the registry are indexed under Nut Hypersensitivity; 9 are open to participants now.
This study's planned enrollment of 40 is below the median of 240 across 11 observational studies indexed under Nut Hypersensitivity.
Browse Nut Hypersensitivity studies →Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.
Compared within Nut Hypersensitivity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Food Hypersensitivity. The counts are of registry records indexed under each term, refreshed daily. How we classify →
All patients from 0 to 18 years old followed in allergology at the University Hospital of Nancy benefiting from oral immunotherapy with cashew nuts for at least 18 months as of 02/28/2023
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: No intervention
No intervention, it's an observational study
Number of allergic reaction
Time frame: during 6 months
Predictive factor of good tolerance
age at onset
Time frame: during 6 months
antibody variation
Modification of level of specific IgE and IGg4 with cashew nuts
Time frame: during 6 months
sustained unresponsiveness
Tolerance of 1, 2, 4, 8g in isolated doses and 15g in total cumulative dose of cashew nuts during an oral challenge test with cashew nuts 3 months after stopping the daily consumption of 2g of cashew nuts
Time frame: 9 months
oral tolerance of pistachio
Tolerance of 1, 2, 4, 8g in isolated doses and 15g in total cumulative dose of pistachio during an oral provocation test with pistachio 3 months after stopping the daily consumption of 2g of cashew nuts
Time frame: 6 months
Predictive factor of good tolerance
antecedent of severe allergic reaction
Time frame: 6 months
Predictive factor of good tolerance
initial reactogenic threshold
Time frame: 6 months
Predictive factor of good tolerance
presence atopy (asthma, food allergy or atopic dermatitis)
Time frame: 6 months
Predictive factor of good tolerance
initial specific IgE and Ana o3 levels
Time frame: 6 months
No study locations are listed for this record.
Start is estimated for May 2023; primary completion for May 2023, 0 months later.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France →